Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-059770
Filing Date
2012-11-06
Accepted
2012-11-06 16:55:35
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v325139_10q.htm 10-Q 427159
2 EX-31.1 v325139_ex31-1.htm EX-31.1 9119
3 EX-31.2 v325139_ex31-2.htm EX-31.2 8770
4 EX-32.1 v325139_ex32-1.htm EX-32.1 4442
  Complete submission text file 0001144204-12-059770.txt   2789998

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20120930.xml EX-101.INS 337680
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20120930.xsd EX-101.SCH 31504
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20120930_cal.xml EX-101.CAL 38333
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20120930_def.xml EX-101.DEF 165992
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20120930_lab.xml EX-101.LAB 234907
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20120930_pre.xml EX-101.PRE 198579
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 121183866
SIC: 2834 Pharmaceutical Preparations